Japan’s cost-effectiveness assessment (CEA) panel has approved a revised handling policy for the CEA system for FY2026, with the health…
HOME > ARCHIVE
ARCHIVE
- Seijo to Tie Up with Yoshioka Sante to Reach Sales of \158 Bil.
November 5, 2001
- BUSINESS NEWS IN BRIEF
November 5, 2001
- Yamanouchi Aims at Consumer Products Sales of \150 Bil. in 2005
November 5, 2001
- Shionogi, GSK Reach FinalAgreement for Joint Venture
November 5, 2001
- Prices of Medical Devices Are Secondary Matters: Mr Rozynski of AdvaMed
November 5, 2001
- Mitsubishi Chemical Safety Institute Establishes Alliance with PRXL
November 5, 2001
- MEDICAL DEVICE NEWS IN BRIEF
November 5, 2001
- NBI, Daiichi Provide Results of Immediate PMS for Mobic
November 5, 2001
- WORLD NEWS IN BRIEF
November 5, 2001
- Toyobo, Nichirei to Form Contract Mfg. Firm of Antibody Drugs
November 5, 2001
- RESEARCH AND DEVELOPMENT NEWS IN BRIEF
November 5, 2001
- Use of Corticosteroid Is Low: GSK Survey Results
November 5, 2001
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
November 5, 2001
- MEDICAL DEVICE NEWS IN BRIEF
October 29, 2001
- Korosho to Control Growth of Medical Spending for Elderly at All Medical Institutions
October 29, 2001
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
October 29, 2001
- METI's Position Paper Calls For Greater Freedom in Healthcare Services
October 29, 2001
- DIAGNOSTIC NEWS IN BRIEF
October 29, 2001
- REGULATORY NEWS IN BRIEF
October 29, 2001
- OTC NEWS IN BRIEF
October 29, 2001
ページ
The launch of Elevidys has opened the door to gene therapy for DMD, but research into new treatments is already…
I recently sat down with one of the leading medical directors in Japan to discuss the critical evolution of the medical science liaison (MSL) role.The MSL has transformed from a scientific resource into a strategic partner essential for successful product…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…